newsfilter
← Latest News
GlobeNewswire·

GBT Announces Pricing of Upsized Offering of $300.0 Million of Convertible Senior Notes

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced the pricing of $300.0 million aggregate principal amount of its Convertible Senior Notes due 2028 (the "notes") in a priva